KOL Lunch on Gene Therapy for Sanfilippo type A (MPS IIIA), hosted by Lysogene (EPA: LYS)

The meeting will feature a presentation by key opinion leader (KOL) Ronald G. Crystal, MD (Weill Cornell Medical College), who will discuss the current landscape for using gene therapeutics for treating patients with CNS degenerative disorders such as mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A.